Consultation psychiatry in COVID-19 patients: Lopinavir/ritonavir interactions with main psychiatric drugs

Psychiatry Clin Neurosci. 2021 Apr;75(4):145-146. doi: 10.1111/pcn.13205. Epub 2021 Feb 25.

Authors

Matteo Marcatili¹, Alberto Stefana², Fabrizia Colmegna¹, Ester di Giacomo^{1

3}, Emiliano D'Amico³, Enrico Capuzzi¹, Antonios Dakanalis³, Massimo Clerici^{1

3}

Affiliations

¹ Psychiatric Department, San Gerardo Hospital, ASST Monza, Monza, Italy.
² Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
³ Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Drug Treatment*
Drug Interactions
Humans
Hypericum*
Long QT Syndrome / chemically induced*
Lopinavir / pharmacology*
Psychiatry
Psychotropic Drugs / pharmacokinetics
Psychotropic Drugs / pharmacology*
Referral and Consultation
Ritonavir / pharmacology*
Viral Protease Inhibitors / pharmacology*

Substances

Psychotropic Drugs
Viral Protease Inhibitors
Lopinavir
Ritonavir